Skip to content
CONTACT
Contact Us
Office Locations
CAREERS
MEDIA
IMPORTANT NOTICE – LISINOPRIL 40MG
Search for:
ABOUT US
About Us
Corporate Overview
Major Milestones
Leadership
Code of Conduct
Compliance & Ethics Program
PATIENT EDUCATION
Albuterol Sulfate Inhalation
SPECIALTY
Specialty
Specialty Strategy
Branded Products
Business Development
Patent Information
GENERICS
Generics
Products
MEDICAL AFFAIRS
Medical Affairs
United States Medical Affairs
Global Clinical Development and Clinical Operations
PRODUCT DEVELOPMENT
Product Development
Inhalation Research
Microsieve Technology
LIFE AT LUPIN
Why Lupin?
Lupin U.S. Locations
Current Openings
RESOURCES
Return Goods Policy
Pharmacovigilance Privacy statement
Globe
AUSTRALIA
BRAZIL
CANADA
GERMANY
INDIA
MEXICO
PHILIPPINES
RUSSIA
SOUTH AFRICA
SWITZERLAND
NETHERLANDS
USA
Leadership
Lupin Pharmaceuticals
2022-12-05T12:44:43+05:30
Leadership
ABOUT US
CORPORATE OVERVIEW
LEADERSHIP
MAJOR MILESTONES
CODE OF CONDUCT
COMPLIANCE & ETHICS PROGRAM
LUPIN U.S. LEADERSHIP
Deep industry experience and a heritage of innovation define Lupin’s U.S. leadership.
Vinita Gupta
CEO
Dr. Sofia Mumtaz
President, Pipeline Management and Legal
Spiro Gavaris
President - US Generics
Bob Hoffman
Chief Commercial Officer, US Generics
Dave Berthold
Senior Vice President, Generics
Gregory Kaufman, MD
Senior Vice President, Global Clinical
and Medical Affairs – Specialty
Kalpana Vanam
Senior Vice President,
Regulatory Affairs
Minaksi Bhatt
Senior Vice President, Global Intellectual Property